Th e GINECO trial explored the combination of trastuzumab with paclitaxel and carboplatin in patients with resistant AOC (< 6 months) and HER2 gene amplification. Patients and Methods: A total of ...

Pooled Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone in Patients With Advanced Melanoma In the article accompanying this editorial, Jensen et al 20 provide an update on the READ ...

After chemotherapy failure, if the cancer is also resistant to endocrine therapy, patients face a double obstacle: few ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Herceptin SC? Herceptin SC contains the active ...

Common hormone therapies include: HER2-Positive Breast Cancer: Drugs like trastuzumab (Herceptin ... Drugs like pembrolizumab (Keytruda) can be used in combination with chemotherapy to enhance the ...

The former Bond Girl, 72, who rose to fame in 1977's The Spy Who Loved Me, refused traditional treatment options to battle ...

Virologist Beata Halassy says self-treatment worked and was a positive experience — but researchers warn that it is not ...

Regimens combining trastuzumab with paclitaxel or with doxorubicin (or epirubicin) plus cyclophosphamide are associated with improved response rates, a longer median time to disease progression ...

PDUFA date for potential approval of Zanidatamab is set for Nov 29, developed in collaboration with Jazz Pharmaceuticals and BeiGene. Find out why ZYME stock is a Buy.

Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...